Salt CompositionMetformin 500mg + Voglibose 0.2mg
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Customers also bought
More About Vogdial M 500mg/0.2mg Tablet
Side Effects
Side effects of Vogdial M Tablet The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Vogdial MFlatulence Diarrhea Vomiting Abdominal pain Bloating Constipation Decreased appetite
How to use
How to use Vogdial M Tablet Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Vogdial M 500mg/0.2mg Tablet is to be taken with food.
How it works
How Vogdial M Tablet works Vogdial M 500mg/0.2mg Tablet is a combination of two antidiabetic medicines:.
Unsafe: Avoid consuming alcohol with Vogdial M 500mg/0.2mg Tablet as it is deemed unsafe.
Vogdial M 500mg/0.2mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Vogdial M 500mg/0.2mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Vogdial M 500mg/0.2mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Vogdial M 500mg/0.2mg Tablet may be needed. Doctor consultation is advised.Use of Vogdial M 500mg/0.2mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Vogdial M 500mg/0.2mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Vogdial M 500mg/0.2mg Tablet may be needed. Doctor consultation is advised.Vogdial M 500mg/0.2mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Manufacturer Address
No. 3502, Ankleshwar GIDC, Ankleshwar, Gujarat 393001
References
CiplaMed. Voglibose + Metformin hydrochloride (08 Apr. 2019)
Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company (08 Apr. 2019)
Metformin hydrochloride oral solution. Gloversville, New York: Ranbaxy Pharmaceuticals Inc.; 2003 (08 Apr. 2019)
Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7 (08 Apr. 2019)
Metformin hydrochloride and Voglibose (Tablets) (21 Oct. 2021)
Voglibose and Metformin Hydrochloride Tablets (28th Sept. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
